Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MINNEBRO proper use and hyperkalemia survey using MID-NET
jRCT2031200204Recruiting
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of finerenone in hypertension (HTN), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoints: Serum potassium testing implementation and Development of hyperkalemia. Started Jan 2009; status: recruiting.
02
Drugs
finerenone
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on jRCT2031200204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031200204.